Copyright Reports & Markets. All rights reserved.

Global Medical Dry Powder Inhalers (DPIs) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Single Dose
    • 1.3.3 Multi Dose
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Asthma
    • 1.4.3 COPD
    • 1.4.4 Others
  • 1.5 Global Medical Dry Powder Inhalers (DPIs) Market Size & Forecast
    • 1.5.1 Global Medical Dry Powder Inhalers (DPIs) Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Medical Dry Powder Inhalers (DPIs) Sales Quantity (2021-2032)
    • 1.5.3 Global Medical Dry Powder Inhalers (DPIs) Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 GlaxoSmithKline
    • 2.1.1 GlaxoSmithKline Details
    • 2.1.2 GlaxoSmithKline Major Business
    • 2.1.3 GlaxoSmithKline Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.1.4 GlaxoSmithKline Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 GlaxoSmithKline Recent Developments/Updates
  • 2.2 AstraZeneca
    • 2.2.1 AstraZeneca Details
    • 2.2.2 AstraZeneca Major Business
    • 2.2.3 AstraZeneca Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.2.4 AstraZeneca Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 AstraZeneca Recent Developments/Updates
  • 2.3 Boehringer Ingelheim
    • 2.3.1 Boehringer Ingelheim Details
    • 2.3.2 Boehringer Ingelheim Major Business
    • 2.3.3 Boehringer Ingelheim Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.3.4 Boehringer Ingelheim Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.4 Chiesi
    • 2.4.1 Chiesi Details
    • 2.4.2 Chiesi Major Business
    • 2.4.3 Chiesi Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.4.4 Chiesi Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Chiesi Recent Developments/Updates
  • 2.5 Cipla
    • 2.5.1 Cipla Details
    • 2.5.2 Cipla Major Business
    • 2.5.3 Cipla Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.5.4 Cipla Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Cipla Recent Developments/Updates
  • 2.6 3M
    • 2.6.1 3M Details
    • 2.6.2 3M Major Business
    • 2.6.3 3M Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.6.4 3M Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 3M Recent Developments/Updates
  • 2.7 Hovione
    • 2.7.1 Hovione Details
    • 2.7.2 Hovione Major Business
    • 2.7.3 Hovione Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.7.4 Hovione Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hovione Recent Developments/Updates
  • 2.8 Mannkind
    • 2.8.1 Mannkind Details
    • 2.8.2 Mannkind Major Business
    • 2.8.3 Mannkind Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.8.4 Mannkind Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Mannkind Recent Developments/Updates
  • 2.9 Mylan
    • 2.9.1 Mylan Details
    • 2.9.2 Mylan Major Business
    • 2.9.3 Mylan Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.9.4 Mylan Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Mylan Recent Developments/Updates
  • 2.10 Novartis
    • 2.10.1 Novartis Details
    • 2.10.2 Novartis Major Business
    • 2.10.3 Novartis Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.10.4 Novartis Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Novartis Recent Developments/Updates
  • 2.11 Schering/Merck
    • 2.11.1 Schering/Merck Details
    • 2.11.2 Schering/Merck Major Business
    • 2.11.3 Schering/Merck Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.11.4 Schering/Merck Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Schering/Merck Recent Developments/Updates
  • 2.12 Teva
    • 2.12.1 Teva Details
    • 2.12.2 Teva Major Business
    • 2.12.3 Teva Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.12.4 Teva Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Teva Recent Developments/Updates
  • 2.13 Vectura
    • 2.13.1 Vectura Details
    • 2.13.2 Vectura Major Business
    • 2.13.3 Vectura Medical Dry Powder Inhalers (DPIs) Product and Services
    • 2.13.4 Vectura Medical Dry Powder Inhalers (DPIs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Vectura Recent Developments/Updates

3 Competitive Environment: Medical Dry Powder Inhalers (DPIs) by Manufacturer

  • 3.1 Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Medical Dry Powder Inhalers (DPIs) Revenue by Manufacturer (2021-2026)
  • 3.3 Global Medical Dry Powder Inhalers (DPIs) Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Medical Dry Powder Inhalers (DPIs) by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Medical Dry Powder Inhalers (DPIs) Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Medical Dry Powder Inhalers (DPIs) Manufacturer Market Share in 2025
  • 3.5 Medical Dry Powder Inhalers (DPIs) Market: Overall Company Footprint Analysis
    • 3.5.1 Medical Dry Powder Inhalers (DPIs) Market: Region Footprint
    • 3.5.2 Medical Dry Powder Inhalers (DPIs) Market: Company Product Type Footprint
    • 3.5.3 Medical Dry Powder Inhalers (DPIs) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medical Dry Powder Inhalers (DPIs) Market Size by Region
    • 4.1.1 Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Region (2021-2032)
    • 4.1.3 Global Medical Dry Powder Inhalers (DPIs) Average Price by Region (2021-2032)
  • 4.2 North America Medical Dry Powder Inhalers (DPIs) Consumption Value (2021-2032)
  • 4.3 Europe Medical Dry Powder Inhalers (DPIs) Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Medical Dry Powder Inhalers (DPIs) Consumption Value (2021-2032)
  • 4.5 South America Medical Dry Powder Inhalers (DPIs) Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Medical Dry Powder Inhalers (DPIs) Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2021-2032)
  • 5.2 Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Type (2021-2032)
  • 5.3 Global Medical Dry Powder Inhalers (DPIs) Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2021-2032)
  • 6.2 Global Medical Dry Powder Inhalers (DPIs) Consumption Value by Application (2021-2032)
  • 6.3 Global Medical Dry Powder Inhalers (DPIs) Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2021-2032)
  • 7.2 North America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2021-2032)
  • 7.3 North America Medical Dry Powder Inhalers (DPIs) Market Size by Country
    • 7.3.1 North America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2021-2032)
  • 8.2 Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2021-2032)
  • 8.3 Europe Medical Dry Powder Inhalers (DPIs) Market Size by Country
    • 8.3.1 Europe Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Medical Dry Powder Inhalers (DPIs) Market Size by Region
    • 9.3.1 Asia-Pacific Medical Dry Powder Inhalers (DPIs) Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Medical Dry Powder Inhalers (DPIs) Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2021-2032)
  • 10.2 South America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2021-2032)
  • 10.3 South America Medical Dry Powder Inhalers (DPIs) Market Size by Country
    • 10.3.1 South America Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Medical Dry Powder Inhalers (DPIs) Market Size by Country
    • 11.3.1 Middle East & Africa Medical Dry Powder Inhalers (DPIs) Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Medical Dry Powder Inhalers (DPIs) Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Medical Dry Powder Inhalers (DPIs) Market Drivers
  • 12.2 Medical Dry Powder Inhalers (DPIs) Market Restraints
  • 12.3 Medical Dry Powder Inhalers (DPIs) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medical Dry Powder Inhalers (DPIs) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medical Dry Powder Inhalers (DPIs)
  • 13.3 Medical Dry Powder Inhalers (DPIs) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medical Dry Powder Inhalers (DPIs) Typical Distributors
  • 14.3 Medical Dry Powder Inhalers (DPIs) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Medical Dry Powder Inhalers (DPIs) market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Medical Dry Powder Inhalers (DPIs) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Medical Dry Powder Inhalers (DPIs) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Medical Dry Powder Inhalers (DPIs) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Medical Dry Powder Inhalers (DPIs) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Medical Dry Powder Inhalers (DPIs) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Medical Dry Powder Inhalers (DPIs)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Medical Dry Powder Inhalers (DPIs) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Mylan, Novartis, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Medical Dry Powder Inhalers (DPIs) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Single Dose
    Multi Dose
    Market segment by Application
    Asthma
    COPD
    Others
    Major players covered
    GlaxoSmithKline
    AstraZeneca
    Boehringer Ingelheim
    Chiesi
    Cipla
    3M
    Hovione
    Mannkind
    Mylan
    Novartis
    Schering/Merck
    Teva
    Vectura
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Medical Dry Powder Inhalers (DPIs) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Medical Dry Powder Inhalers (DPIs), with price, sales quantity, revenue, and global market share of Medical Dry Powder Inhalers (DPIs) from 2021 to 2026.
    Chapter 3, the Medical Dry Powder Inhalers (DPIs) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Medical Dry Powder Inhalers (DPIs) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Dry Powder Inhalers (DPIs) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Dry Powder Inhalers (DPIs).
    Chapter 14 and 15, to describe Medical Dry Powder Inhalers (DPIs) sales channel, distributors, customers, research findings and conclusion.

    Buy now